Comparing biologic treatments for inflammatory bowel disease after one year
Part of Digestive system clinical trials.
This trial compares different biologic medications (adalimumab, infliximab, ustekinumab, or vedolizumab) to see how well they work after one year in people with moderate-to-severe ulcerative colitis or Crohn's disease. It aims to find which treatment is most effective for patients in Upper Egypt.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have moderate-to-severe ulcerative colitis or Crohn's disease
- You are currently taking one of these biologics: adalimumab, infliximab, ustekinumab, or vedolizumab
- You have been on your current biologic for at least 6 weeks and no more than 12 months
- You have never taken a biologic before (you are biologic-naive)
- You are not pregnant and have not had any breaks in your treatment over the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different biologic medications to see which best prevents Crohn's disease from coming back after intestinal surgery. It may help you if you have had surgery for Crohn's and are starting a biologic drug soon after.
This trial compares three types of medications (vedolizumab, ustekinumab, and JAK inhibitors) in people with ulcerative colitis who have already tried an anti-TNF drug but still have active disease. The goal is to see which treatment works best as a second option.
This study compares different blood tests that measure the amount of biologic medication in your body. The goal is to see if simpler tests give the same results as standard ones, which could make monitoring easier for patients with inflammatory bowel disease.
This trial tests three different types of biologic medications to find which works best as a first treatment for moderate-to-severe ulcerative colitis.
This trial compares how well different combinations of drugs calm inflammation in the gut compared to single drugs. It uses tissue samples taken during a colonoscopy to see which approach works best for people with inflammatory bowel disease.
This study is for children and teens with inflammatory bowel disease (Crohn's, colitis, or indeterminate) whose previous anti-TNF medicine stopped working. It compares several newer treatments to see which works best.
Hear when a new Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.